SYNTHETIC PEPTIDES THAT MIMIC THE BINDING-SITE OF HORSESHOE-CRAB ANTILIPOPOLYSACCHARIDE FACTOR

被引:42
作者
KLOCZEWIAK, M
BLACK, KM
LOISELLE, P
CAVAILLON, JM
WAINWRIGHT, N
WARREN, HS
机构
[1] MASSACHUSETTS GEN HOSP,SHRINERS BURNS INST,DEPT SURG,BOSTON,MA 02114
[2] MASSACHUSETTS GEN HOSP,SHRINERS BURNS INST,DEPT MED,BOSTON,MA 02114
[3] MASSACHUSETTS GEN HOSP,SHRINERS BURNS INST,DEPT PEDIAT,BOSTON,MA 02114
[4] HARVARD UNIV,SCH MED,BOSTON,MA
[5] MARINE BIOL LABS,WOODS HOLE,MA
[6] INST PASTEUR,DEPT IMMUNOALLERGY,PARIS,FRANCE
关键词
D O I
10.1093/infdis/170.6.1490
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tachypleus antilipopolysaccharide (LPS) factor (TALF) is a protein of 102 amino acids in the lysate of amebocytes of Tachypleus tridentatus that binds bacterial LPS with high affinity and blocks its biologic activity in numerous assays. To elucidate the minimal sequences that bind LPS, overlapping synthetic peptides based on the sequence of TALF were assessed for the ability to bind and neutralize LPS. TALF41-53 was the minimal sequence that bound LPS, as assessed by a slot blot capture assay. TALF29-59 bound LPS with the highest potency. TALF29-59 decreased LPS-induced coagulation of limulus amebocyte lysate, induction of cytokines from human monocytes, and LPS-induced lethality in sensitized mice. Synthetic peptides based on TALF or other LPS-binding proteins may be useful for the design of drugs for treatment of endotoxemia.
引用
收藏
页码:1490 / 1497
页数:8
相关论文
共 33 条
  • [1] LIMULUS ANTILIPOPOLYSACCHARIDE FACTOR PROTECTS RABBITS FROM MENINGOCOCCAL ENDOTOXIN-SHOCK
    ALPERT, G
    BALDWIN, G
    THOMPSON, C
    WAINWRIGHT, N
    NOVITSKY, TJ
    GILLIS, Z
    PARSONNET, J
    FLEISHER, GR
    SIBER, GR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) : 494 - 500
  • [2] CYCLIC RGD PEPTIDE ANALOGS AS ANTIPLATELET ANTITHROMBOTICS
    BARKER, PL
    BULLENS, S
    BUNTING, S
    BURDICK, DJ
    CHAN, KS
    DEISHER, T
    EIGENBROT, C
    GADEK, TR
    GANTZOS, R
    LIPARI, MT
    MUIR, CD
    NAPIER, MA
    PITTI, RM
    PADUA, A
    QUAN, C
    STANLEY, M
    STRUBLE, M
    TOM, JYK
    BURNIER, JP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (11) : 2040 - 2048
  • [3] POSSIBLE ALTERATION OF NORMAL MECHANISMS OF ENDOTOXIN TOXICITY INVIVO BY ACTINOMYCIN-D
    BROWN, DE
    MORRISON, DC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1982, 146 (06) : 746 - 750
  • [4] LIPOPOLYSACCHARIDE (LPS)-REACTIVE MONOCLONAL-ANTIBODIES FAIL TO INHIBIT LPS-INDUCED TUMOR NECROSIS FACTOR SECRETION BY MOUSE-DERIVED MACROPHAGES
    CHIA, JKS
    POLLACK, M
    GUELDE, G
    KOLES, NL
    MILLER, M
    EVANS, ME
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (05) : 872 - 880
  • [5] ANTILIPOPOLYSACCHARIDE FACTOR FROM HORSESHOE-CRAB, TACHYPLEUS-TRIDENTATUS, INHIBITS LIPOPOLYSACCHARIDE ACTIVATION OF CULTURED HUMAN-ENDOTHELIAL CELLS
    DESCH, CE
    OHARA, P
    HARLAN, JM
    [J]. INFECTION AND IMMUNITY, 1989, 57 (05) : 1612 - 1614
  • [6] LIPOPOLYSACCHARIDE DETOXIFICATION BY ENDOTOXIN NEUTRALIZING PROTEIN
    FLETCHER, MA
    MCKENNA, TM
    QUANCE, JL
    WAINWRIGHT, NR
    WILLIAMS, TJ
    [J]. JOURNAL OF SURGICAL RESEARCH, 1993, 55 (02) : 147 - 154
  • [7] GREISMAN SE, 1973, J IMMUNOL, V111, P1349
  • [8] CRYSTAL-STRUCTURE OF AN ENDOTOXIN-NEUTRALIZING PROTEIN FROM THE HORSESHOE-CRAB, LIMULUS ANTI-LPS FACTOR, AT 1.5 ANGSTROM RESOLUTION
    HOESS, A
    WATSON, S
    SIBER, GR
    LIDDINGTON, R
    [J]. EMBO JOURNAL, 1993, 12 (09) : 3351 - 3356
  • [10] FUNCTIONAL ACTIVITIES OF MONOCLONAL-ANTIBODIES TO THE O SIDE-CHAIN OF ESCHERICHIA-COLI LIPOPOLYSACCHARIDES INVITRO AND INVIVO
    KIM, KS
    KANG, JH
    CROSS, AS
    KAUFMAN, B
    ZOLLINGER, W
    SADOFF, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (01) : 47 - 53